Stock Rich List
Nasdaq: BBIO

BridgeBio Pharma insiders

The officers, directors and 10% owners of BridgeBio Pharma, Inc. who hold the most stock, valued at the live BBIO price.

$78.18
BBIO today +$170K (+0.22%)
Market closed. Prices as of Nov 19, 4:04 PM ET
Ranked insiders
11
Their BBIO stock
$641M
Market value
$15.20B
Held by ranked insiders
4.22%

Insiders by value of BBIO holdings

SEC ownership page
#InsiderRoleSharesValueOf companyOverall rank
1Neil KumarChief Executive Officer5,598,126$438M2.88%525th
2Charles J. HomcyDirector919,876$71.9M0.47%1924th
3Frank McCormickDirector767,244$60.0M0.39%2240th
4Thomas TrimarchiPresident and CFO313,748$24.5M0.16%4438th
5Ali J. SatvatDirector169,983$13.3M<0.1%7082nd
6Maricel ApuliChief Accounting Officer115,973$9.1M<0.1%9440th
7Brian C. StephensonCFO and Treasurer102,464$8.0M<0.1%9997th
8James C. MomtazeeDirector99,070$7.7M<0.1%7605th
9Andrew LoDirector68,662$5.4M<0.1%10957th
10Fred HassanDirector29,879$2.3M<0.1%9292nd
11Brent L. SaundersDirector17,600$1.4M<0.1%3423rd

Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for BridgeBio Pharma; see each profile for the filing.